Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Terapeutisk cancervaccination mod hæmatologisk cancer

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Androgent insensitivitetssyndrom opdaget pga. diskordans mellem prænatale vurderinger af fosterkøn.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Behandling af tymom og thymuskarcinom

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Bilateral caput femoris-epifysiolyse efter epileptisk anfald

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Osmotisk demyeliniseringssyndrom

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Uafklaret dyspnø.

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

    Research output: Contribution to journalReviewResearchpeer-review

  2. Inflammation induced PD-L1-specific T cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Peripheral memory T cells specific for Arginase-1

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Few trials testing the clinical efficacy of therapeutic cancer vaccination have been successful, and therapeutic cancer vaccines are yet to enter the clinic for treatment of haematological cancers. The review summarises the present knowledge of the interplay between cancer and the immune system. These novel insights have uncovered knowledge, which can be used to enhance the effect of therapeutic cancer vaccines in haematology. Immune checkpoint inhibitors, immunomodulating agents, radiotherapy and vaccination against regulatory mechanisms can potentially increase the clinical effect of cancer vaccines for haematological cancer.

Translated title of the contributionTherapeutic cancer vaccination for treatment of haematological cancers
Original languageDanish
JournalUgeskrift for Laeger
Volume181
Issue number20A
ISSN0041-5782
Publication statusPublished - 14 Oct 2019

ID: 58521609